Skip to content

Advertisement

Volume 16 Supplement 1

1st Joint ANIRCEF-SISC Congress

  • Invited speaker presentation
  • Open Access

Disability and quality of life in patients with different forms of migraine

  • 1Email author,
  • 2,
  • 1,
  • 1 and
  • 2
The Journal of Headache and Pain201516 (Suppl 1) :A4

https://doi.org/10.1186/1129-2377-16-S1-A4

  • Published:

Keywords

  • Migraine
  • Leisure Activity
  • Life Tool
  • Healthcare Intervention
  • Disability Level

Background and state of the art

Migraine (M) is the seventh leading cause of years of life lost to disability (YLDs) worldwide, responsible for 2.9% of all YLDs, more than half of all YLDs attributable to neurological disorders[1]. Its negative effects result from several studies, particularly in surveys carried out by our research group, through the application of patient oriented outcome measures (PROMS), and in their development and validation[24]. Administration of MIDAS (a migraine-specific tool) demonstrated that: the disability level is rather high (particularly in chronic M); social, family and leisure activities are more impaired than work activities; days spent at work with reduced effectiveness are more than days of absence[35]. A better understanding of the pervasive impact of migraine has been achieved using the WHODAS 2.0, a questionnaire based on the International Classification of Functioning, which captures the interaction between the individual's health status and the context of life. Our data, together with many results deriving from the application of quality of life tools (e.g., SF-36 and MSQ), showed that migraine influences physical and emotional domains, causes restriction and avoidance of activities also outside the headache episodes[611].

Measuring the impact of migraine: a relevant issue in different fields

Migraine has to be considered both as a clinical and as a public health problem: therefore, at least two perspectives need to be taken into account:

1. Epidemiological and healthcare perspectives: to evaluate the burden of migraine in the population, understand patients’ needs in implementing appropriate treatments and address healthcare interventions.

2. Clinical practice and research perspectives: to assess the severity of migraine in an individual patient, to better tailor treatment plans, and eventually to evaluate their global outcome, and to assess the efficacy of new treatments in RCTs and observational studies.

Concluding remarks and future directions

Migraine is a common condition, whose impact is relevant on individuals, in terms of personal suffering and reduced health, and on societies, in terms of reduced productivity and increased costs for the health system[7, 8, 12]. The systematic use of PROMs should be encouraged both in the clinical and in the research fields, particularly in RCTs to quantify the potential benefits of treatments. Further (ongoing) research is needed to understand the potential application of the different tools in the different contexts, as well as to develop new instruments to assess the qualitative aspects of migraine-related disability, particularly in the workplace.

Conflict of interest

None declared.

Declarations

Acknowledgements

Part of this study was carried out with an unrestricted grant from Allergan.

Authors’ Affiliations

(1)
Headache and Neuroalgology Unit, Neurological Institute C. Besta, IRCCS Foundation, Milan, Italy
(2)
Neurology, Public Health and Disability Unit, Neurological Institute C. Besta, IRCCS Foundation, Milan, Italy

References

  1. Steiner TJ, Stovner LJ, Birbeck GL: Migraine: the seventh disabler. J Headache Pain. 2013, 14: 1-10.1186/1129-2377-14-1.PubMed CentralView ArticlePubMedGoogle Scholar
  2. D'Amico D, Mosconi P, Genco S, et al: The Migraine Disability Assessment (MIDAS) questionnaire: Translation and reliability of the Italian version. Cephalalgia. 2001, 21: 947-952. 10.1046/j.0333-1024.2001.00277.x.View ArticlePubMedGoogle Scholar
  3. D';Amico D, Grazzi L, Usai S, Leonardi M, Raggi A: Disability and quality of life in headache: where we are now and where we are heading. Neurol Sci. 2013, 34: S1-S5.View ArticleGoogle Scholar
  4. Raggi A, Giovannetti AM, Schiavolin S, Leonardi M, Bussone G, Grazzi L, Usai S, Curone M, Di Fiore P, D'Amico D: Validating the Migraine-Specific Quality of Life Questionnaire v2.1 (MSQ) in Italian inpatients with chronic migraine with a history of medication overuse. Qual Life Res. 2014, 23 (4): 1273-7. 10.1007/s11136-013-0556-9.View ArticlePubMedGoogle Scholar
  5. D'Amico D, Grazzi L, Usai S, Rigamonti A, Curone M, Bussone G: Disability pattern in chronic migraine with medication overuse: a comparison with migraine without aura. Headache. 2005, 45 (5): 553-60. 10.1111/j.1526-4610.2005.05109.x.View ArticlePubMedGoogle Scholar
  6. Raggi A, Giovannetti AM, Quintas R, D'Amico D, Cieza A, Sabariego C, Bickenbach JE, Leonardi M: A systematic review of the psychosocial difficulties relevant to patients with migraine. J Headache Pain. 2012, 13: 595-606. 10.1007/s10194-012-0482-1.PubMed CentralView ArticlePubMedGoogle Scholar
  7. Raggi A, Covelli V, Leonardi M, Grazzi L, Curone M, D'Amico D: Difficulties in work-related activities among migraineurs are scarcely collected: results from a literature review. Neurol Sci. 2014, 35: S23-S26.View ArticleGoogle Scholar
  8. D'Amico D, Grazzi L, Curone M, Di Fiore P, Cecchini Proietti A, Leonardi M, Scaratti C, Raggi A: Difficulties in work activities and the pervasive effect over disability in patients with episodic and chronic migraine. Neurol Sci. 2015, 36: S9-S11. 10.1007/s10072-015-2130-4.View ArticleGoogle Scholar
  9. Leonardi M, Raggi A, Bussone G, D'Amico D: Health-related quality of life, disability and severity of disease in patients with migraine attending to a specialty headache center. Headache. 2010, 50: 1576-1586. 10.1111/j.1526-4610.2010.01770.x.View ArticlePubMedGoogle Scholar
  10. Raggi A, Leonardi M, Bussone G, D'Amico D: A 3-month analysis of disability, quality of life and disease course in patients with migraine. Headache. 2013, 53: 297-309. 10.1111/j.1526-4610.2012.02279.x.View ArticlePubMedGoogle Scholar
  11. Raggi A, Schiavolin S, Leonardi M, Giovannetti AM, Bussone G, Curone M, Di Fiore P, Grazzi L, Usai S, D'Amico D: Chronic Migraine with Medication Overuse: association between disability and quality of life measures, and impact of disease on patients” lives. J Neurol Sci. 2015, 348: 60-66. 10.1016/j.jns.2014.11.004.View ArticlePubMedGoogle Scholar
  12. Linde M, Gustavsson A, Stovner LJ, Steiner TJ, Barré J, Katsarava Z, Lainez JM, Lampl C, Lantéri-Minet M, Rastenyte D, Ruiz de la Torre E, Tassorelli C, Andrée C: The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol. 2012, 19: 703-11. 10.1111/j.1468-1331.2011.03612.x.View ArticlePubMedGoogle Scholar

Copyright

© D'Amico et al. 2015

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Please note that comments may be removed without notice if they are flagged by another user or do not comply with our community guidelines.

Advertisement